Abstract
Cerebellar granule and glial cells prepared from 7 day-old rat pups were used to investigate the effects of sub-acute nicotine exposure on the glutamatergic nervous system. These cells were exposed to nicotine in various concentrations for 2 to 10 daysin situ. Nicotine-exposure did not result in any changes in cerebellar granule and glial cell viability at concentrations of up to 500 μM. In cerebellar granule cells, the basal extracellular levels of glutamate, aspartate and glycine were enhanced in the nicotine-exposed granule cells. In addition, the responses of N-methyl-D-aspartate (NMDA)-induced glutamate release were enhanced at low NMDA concentrations in the nicotine-exposed granule cells. However, this decreased at higher NMDA concentrations. The glutaminase activity was increased after nicotine exposure. In cerebellar glial cells, glutamate uptake in the nicotine-exposed glial cells were either increased at low nicotine, exposure levels or decreased at higher levels. The inhibition of glutamate uptake by L-trans-pyrollidine-2,4-dicarboxylic acid (PDC) was lower in glial cells exposed to 50μM nicotine. Glutamine synthetase activity was lower in glial cells exposed to 100 or 500 μM of nicotine. These results indicate that the properties of cerebellar granule and glial cells may alter after subacute nicotine exposure. Furthermore, they suggest that nicotine exposure during development may modulate glutamatergic nervous activity.
Similar content being viewed by others
References
Akaike, N., Harata, N. and Tateishi, N., Modulatory action of cholinergic drugs on NMDA response in dissociated rat nucleus basalis of Meynert neurons.Neurosci. Lett., 130, 243–247 (1991).
Akaike, A., Tamura, Y., Yokota, T., Shimohama, S. and Kimura, J., Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity.Brain Res., 644, 181–187 (1994).
Alavez, S., Gutierrez, L. and Moran, J., Characterization of the activation of glutaminase induced by N-methyl-D-aspartate and potassium in cerebellar granule cells.J. Neurosci. Res., 45, 637–646 (1997).
Aramakis, V. B. and Metherate, R., Nicotine selectively enhances NMDA receptor-mediated synaptic transmission during postnatal development in sensory neocortex.J. Neurosci., 18, 8485–8494 (1998).
Berger, F., Gage, F and Vijayaraghavan, S., Nicotinic receptor-induced apoptotic cell death of hippocampal progentor cells.J. Neurosci., 18, 6871–6881 (1998).
Birtwistle, J. and Hall, K., Does nicotine have beneficial effects in the treatment of certain diseases?Br. J. Nurs., 5, 1195–1202 (1997).
Borlongan, C. V., Shytle, R. D., Ross, S. D., Shimizu, T., Freeman, T. B., Cahill, D. W. and Sanberg, P. R., (−)-Nicotine protects against systemic kainic acid-induced excitotoxic effects.Exp. Neurology, 136, 261–265 (1995).
Caldani, M., Rolland, B., Fages, C. and Tardy, M., Glutamine synthetase activity during mouse brain development.Experientia, 38, 1199–1202 (1982).
Collingridge, G. L. and Lester, R. A. J., Excitatory amino acid receptors in the vertebrate central nervous system.Pharmacol. Rev., 41, 143–210 (1989).
Derouiche, A. and Rauen, T., Coincidence of L-glutamate/L-aspartate transporter (GLAST) and glutamine synthetase (GS) immunoreactions in retinal glia: evidence for coupling of GLAST and GS in transmitter clearence.J. Neurosci. Res., 42, 131–143 (1995).
Didier, M., Berman, S. A., Lindstrom, J. and Bursztajn, S., Characterization of nicotinic acetylcholine receptors expressed in primary cultures of cerebellar granule cells.Mol. Brain Res., 30, 17–28 (1995).
Fairman, W. A., Vandenverg, R. J., Arriza, J. L., Kavanaugh, M. P. and Amara, S. G., An excitatory amino-acid transporter with properties of a ligand-gated chloride channel.Nature, 375, 599–603 (1995).
Fung, Y. K., Schmid, M. J., Anderson, T. M. and Lau, Y., Effects of nicotine withdrawal on central dopaminergic systems.Pharmacol. Biochem. Behav., 53, 635–640 (1996).
Garcia-Munoz, M., Patino, P., Young, S. J. and Groves, P. M., Effects of nicotine on dopaminergic nigrostriatal axons requires stimulation of presynaptic glutamatergic receptors.J. Pharmacol. Exp. Ther., 277, 1685–1693 (1996).
Gattu, M., Pauly, J. R., Boss, K. L., Summers, J. B. and Buccafusco, J. J., Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. I.Brain Res., 771, 89–103 (1997).
Grunewald, M. and Kanner, B., Conformational changes monitored on the glutamate transporter GLT-1 indicate the existence of two neurotransmitter-bound states.J. Biol. Chem., 270, 17017–17024 (1995).
Kim, W. K. and Pae, Y. S., Cellular mechanism, of nicotine-mediated intracelluar calcium homeostasis in primary culture of mouse cerebellar granule cells.Korean J. Pharmacol., 32, 13–21 (1996).
Kondo, K., Hashimoto, H., Kitanaka, J., Sawaka, M., Suzumura, A., Marunouchi, T. and Baba, A., Expression of glutamate transporters in cultured glial cells.Neurosci. Lett., 188, 140–142 (1995).
Lawrence, A. D. and Sahakian, B. J., Alzheimer disease, attention and the cholinergic system.Alzheimer. Dis. Assoc. Disord., 9, 43–49 (1995).
Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J., Protein measurement with the folin phenol reagent.J. Biol. Chem., 193, 265–275 (1951).
McCaslin, P. P. and Morgan, W. W., Cultured cerebellar cells as as in vitro model of excitatory amino acid receptor function.Brain Res., 417, 380–384 (1987).
Meldrum, B. and Garthwaite, J., Excitatory amino acid neurotoxicity and neurodegenerative disease.Trends in Pharmacol. Sci., 11, 379–387 (1990).
Mennerick, S. and Zorumski, C. F., Glial contributions to excitatory neurotransmission in cultured hippocampal cells.Nature, 368, 59–62 (1994).
Miulli, D. E., Norwell, D. Y. and Schwartz, F. N., Plasma concentrations of glutamate and its metabolites in patients with Alzheimer’s disease.J. Am. Osteopath. Assoc., 93, 670–676 (1993).
Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.J. Immunol. Meth., 65, 55–63 (1983).
Oster, Y. and Schramm, M., Down-regulation of NMDA receptor activity by NMDA.Neurosci. Lett., 163, 85–88 (1993).
Nicholis, D. and Attwell, D., The release and uptake of excitatory amino acids.Trends in Pharmacol. Sci., 11, 462–468 (1990).
Perez De La Mora, M., Mendez-Franco, J., Salceda, R., Aguirre, J. A. and Fuxe, K., Neurochemical effects of nicotine on glutamate and GABA mechanisms in the rat brain.Acta. Physiol. Scand., 141, 241–250 (1991).
Resink, A., Villa, M., Benke, D., Hidaka, H., Mohler, H. and Balazs, R., Characterization of agonist-induced down-regulation of NMDA receptors in cerebellar granule cell cultures.J. Neurochem., 66, 369–377 (1996).
Schmid, R., Hong, J. S., Meek, J. and Costa, E., The effects of kainic acid on the hippocampal content of putative neurotransmitter amino acids.Brain Res., 200, 355–362 (1980).
Shoup, R. E., Allison, L. A. and Mayer, G. S., O-phthalaldehyde derivatives of amines for high-speed liquid chromatography/electrochemistry.Analytical Chem., 56, 1089–1096 (1984).
Toth, E., Vizi, E. S. and Lajtha, A., Effect of nicotine on levels of extracellular amino acids in regions of the rat brain in vivo.Neuropharmacology, 32, 827–832 (1993).
Vidal, C., Nicotinic receptors in the brain. Molecular biology, function and therapeutics.Mol. Chem. Neuropathol., 28, 3–11 (1997).
Zhang, X., Gong, Z. and Nordberg, A., Effects of chronic treatment with (+)-and (−)-nicotine on nicotinic acetylcholine receptors and N-methyl-D-aspartate receptors in rat brain.Brain. Res., 644, 32–39 (1994).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lim, D.K., Park, S.H. & Choi, W.J. Subacute nicotine exposure in cultured cerebellar cells increased the release and uptake of glutamate. Arch Pharm Res 23, 488–494 (2000). https://doi.org/10.1007/BF02976578
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02976578